Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
SENS 
Senseonics Holdings, Inc. Common Stock (SENS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/16/2025: SENS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $18.92
1 Year Target Price $18.92
| 1 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 31.94% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 12/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 277.43M USD | Price to earnings Ratio - | 1Y Target Price 18.92 |
Price to earnings Ratio - | 1Y Target Price 18.92 | ||
Volume (30-day avg) 4 | Beta 0.93 | 52 Weeks Range 5.25 - 28.00 | Updated Date 12/16/2025 |
52 Weeks Range 5.25 - 28.00 | Updated Date 12/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -217.65% | Operating Margin (TTM) -242.14% |
Management Effectiveness
Return on Assets (TTM) -32.64% | Return on Equity (TTM) -129.29% |
Valuation
Trailing PE - | Forward PE 21.51 | Enterprise Value 210092451 | Price to Sales(TTM) 9.47 |
Enterprise Value 210092451 | Price to Sales(TTM) 9.47 | ||
Enterprise Value to Revenue 7.17 | Enterprise Value to EBITDA 1.76 | Shares Outstanding 40858460 | Shares Floating 36989572 |
Shares Outstanding 40858460 | Shares Floating 36989572 | ||
Percent Insiders 8.99 | Percent Institutions 15.51 |
About Senseonics Holdings, Inc. Common Stock
Exchange NYSE MKT | Headquaters Germantown, MD, United States | ||
IPO Launch date 2016-03-17 | President, CEO & Director Dr. Timothy T. Goodnow Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 117 | Website https://www.senseonics.com |
Full time employees 117 | Website https://www.senseonics.com | ||
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.